Hyperoxaluria is a rare metabolic disorder that affects the kidneys and urinary tract. It is caused by an excessive accumulation of oxalate in the body, which can lead to kidney stones, kidney failure, and other serious health complications. In the context of Urology and Nephrology, hyperoxaluria is a major concern due to its potential to cause long-term damage to the kidneys and urinary tract. Treatment options for hyperoxaluria include dietary changes, medications, and in some cases, surgery.
The market for hyperoxaluria treatments is relatively small, but is growing as more treatments become available. Companies in the market include Keryx Biopharmaceuticals, which produces a drug called Auryxia, and OxThera, which produces a drug called Oxabact. Other companies in the market include Ardelyx, Inc., which produces a drug called Tenapanor, and Retrophin, Inc., which produces a drug called Thiola. Show Less Read more
